Selenium (as selenious acid)
PronunciationPronunciation: se-LEE-nee-um
Class: Trace metal
Trade Names
Se-100
- Capsules, oral 100 mcg
Selenicaps-200
- Capsules, oral 200 mcg
Selenium
- Capsules, oral 100 mcg
- Capsules, oral 200 mcg
- Tablets, oral 50 mcg
- Tablets, oral 100 mcg
- Tablets, oral 125 mcg
- Tablets, oral 200 mcg
- Tablets, ER, oral 200 mcg
- Injection 40 mcg/mL
Selenimin-50
- Tablets, oral 50 mcg
Selenimin-200
- Tablets, oral 200 mcg
Pharmacology
Part of glutathione peroxidase, which protects cell components from oxidative damage caused by peroxidases produced in cellular metabolism; spares vitamin E, which in turn boosts the cell's antioxidant defense system; plays a role in the structure of teeth.
Pharmacokinetics
Absorption
Selenium is readily absorbed from the GI tract.
Distribution
Selenium is stored in the red blood cells, liver, spleen, heart, and nails.
Metabolism
Once selenium reaches the tissues, it is converted to its active form.
Elimination
Primarily excreted in the urine, and to a lesser extent in the feces.
Indications and Usage
Dietary supplement; use as a supplement to IV TPN solutions to prevent depletion of endogenous stores and subsequent deficiency symptoms.
Contraindications
Do not give injection undiluted by direct IV injection.
Dosage and Administration
Adults PO100 to 200 mcg/day. The 50 mcg tablets may be taken as 1 tablet 4 times daily.
IV Metabolically stable patients20 to 40 mcg/day added to the TPN.
Selenium deficiency states resulting from long-term TPN support100 mcg/day for 31 days has reversed deficiency symptoms without toxicity.
ChildrenIV 3 mcg/kg/day.
General Advice
- Tablets should be taken with meals.
- Do not give injection undiluted by direct injection into a peripheral vein.
- Add injection to TPN solution.
Storage/Stability
Store tablets and capsules in a tightly closed container in a cool, dry place. Store vials between 59° and 86°F.
Drug Interactions
None well documented.
Adverse Reactions
Unlikely to occur at recommended dosage level.
Precautions
MonitorFrequently assess vascular access site for signs of inflammation or infection. Periodic monitoring of selenium plasma levels is suggested as a guideline for subsequent injections. |
Pregnancy
Category C .
Lactation
Undetermined.
Hypersensitivity
Some oral products contain yeast. Avoid these products in patients who are allergic to yeast.
Renal Function
Supplement dosage may need to be adjusted, reduced, or omitted.
Aluminum toxicity
Parenteral products may contain aluminum that may be toxic. Aluminum may reach toxic levels with prolonged parenteral administration if kidney function is impaired. Premature neonates are particularly at risk.
GI malfunction
Dose may need to be adjusted, reduced, or omitted.
Overdosage
Symptoms
AcuteBrick red–color gastric mucosa, cerebral edema, coma, death, edematous lungs, fulminating peripheral vascular collapse, garlicky or sour breath odor, GI effects (eg, vomiting), hemolysis, hypersalivation, internal vascular congestion, liver necrosis, muscle spasms, pulmonary edema, and restlessness.
ChronicDental defects, dermatitis, garlic odor of breath and sweat, GI disorders, hair loss, mental depression, metallic taste, nervousness, vomiting, weakened nails.
Patient Information
- Advise patient to take oral supplements with food.
- Advise patient, family, or caregiver that injection will be added to TPN solution.
- Advise patient to report pain, redness, warmth, or swelling of TPN access site.
Copyright © 2009 Wolters Kluwer Health.


